FDA Can Mandate Recalls of Mascara and Other Cosmetics Found to Violate Safety or Labeling Regulations

FDA in Action: PFAS Data Gaps, MoCRA Recall Guidance, Warning Letters/Recalls and New Hair Growth Pill Reaches Phase III Trials

The U.S. FDA has been busy in recent months, reviewing PFAS in cosmetics, proposing MoCRA-conferred recall guidance, enforcing compliance through warning letters and recalls, and advancing trials for a new hair loss treatment. Following is an overview.

FDA Can Mandate Recalls of Mascara and Other Cosmetics Found to Violate Safety or Labeling Regulations

The U.S. Food and Drug Administration (FDA) has the aut […] The post FDA Can Mandate Recalls of Mascara and Other Cosmetics Found to Violate Safety or Labeling Regulations first appeared on GeneOnline News. The post FDA Can Mandate Recalls of Mascara and Other Cosmetics Found to Violate Safety or Labeling Regulations appeared first on GeneOnline News.

FDA unable to determine safety of ‘forever chemicals’ in cosmetics

A lack of available data on the perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products has left the US Food and Drug Administration (FDA) unable to fully assess their risks